Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News GSK American Depositary Shares Representing 2 Ordinary Shares GSK

Consumer Cyclical
GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. It has developed monoclonal antibodies to help treat different diseases. Its product areas include vaccines, specialty medicines, and general medicine. It is also... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NYSE:GSK)

Positive RUBY phase III data show potential for Jemperli (dostarlimab-gxly) combinations in more patients with primary advanced or recurrent endometrial cancer

Business Wire March 16, 2024

GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising Rise

Business Wire March 7, 2024

Alector Announces First Patient Dosed in PROGRESS-AD Phase 2 Clinical Trial of AL101/GSK4527226 in Patients with Early Alzheimer's Disease

GlobeNewswire February 8, 2024

23andMe Reports Third Quarter Fiscal 2024 Financial Results

GlobeNewswire February 7, 2024

FDA Grants Latozinemab Breakthrough Therapy Designation for Frontotemporal Dementia Due to a Progranulin Gene Mutation (FTD-GRN)

GlobeNewswire February 7, 2024

GSK's RSV Vaccine, AREXVY, Accepted Under Priority Review in US for the Prevention of RSV Disease in Adults Aged 50-59 at Increased Risk

Business Wire February 6, 2024

Elegen and GSK Sign Collaboration and Licensing Agreement to Further Develop Elegen's Cell-Free DNA Production Technology

Business Wire January 24, 2024

GSK Enters Agreement to Acquire Aiolos Bio

Business Wire January 9, 2024

GSK Awards $1M in COiMMUNITY Initiative Grants to Support Adult Immunization and Health Equity

Business Wire December 12, 2023
View More News ››

Opinion & Analysis (NYSE:GSK)

Opportunities in cancer immunotherapy throttle up: George Zavoico of JonesTrading

George S. Mack June 25, 2015

Drug ETFs Surge On M&A Activity (AGN, VRX, IHE, XPH, PPH, AZN)

Benzinga.com  April 22, 2014

Everyone gets the flu

Marc Lichtenfeld March 6, 2013

Cash in on the growing Chinese pharmaceutical market

Tony D'Altorio September 10, 2010

Big Pharma has a big problem and merger mania is heating up

Marc Lichtenfeld July 29, 2010

Stock market myth: share buybacks work

Andrew Mickey October 29, 2008
View More Opinion ››

Bullboard Posts (NYSE:GSK)

Great News !!!! this would be amazing !!

https://www.washingtonpost.com/health/2022/06/08/cancer-drug-trial/ https://nationalpost.com/health/small-cancer-drug-trial-sees...
Thunde - June 9, 2022

Glaxo

Doesn't sell the cure Glaxo Sells the disease
Rainbowflier - May 4, 2022

5% divided with huge upside with split

This company will be more profitable once they split up work it as two companies. Their pipeline of drugs and monoclonal antibody...
CBalardo - October 20, 2021

Bonvoyage12....Lying Pumper

Ignore this clown as he posts lies trying to mislead investors about the actual state of the company...he also posts this same BS on...
Mil_Man54 - December 26, 2020

Why is it so low

I don't understand why this stock is even lower than before the pandemic. They have the potential to enter in the Covid vaccine...
IamMagic - December 1, 2020

This is supposed to be Glasgow Smith Kline!

Seems Stockhouse can't get anything right
prested - November 22, 2016
View more Bullboard ››

Fokus Mining Corp

Fokus Mining Corp

Fokus Mining Corporation is a Canada-based mineral resource company. The Company is engaged in acquiring, exploring and ...
View More »